SG Eyes Pharma, Biotech Offering As M&A Spikes
Société Générale is to launch open-end certificates on a pharma and biotech opportunity index to retail and private banking clients in Germany and Austria following increased M&A activity in the healthcare industry.
Exclusive Insights
Gain actionable intelligence with clarity and speed – practical knowledge you can apply every day.
You must be a subscriber to view this page. Either log in or select “Request Access” below to connect with our subscriptions team.
